Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344848 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the Orion Visual Cortical Prosthesis System
A NA study of Blindness, Acquired, sponsored by Second Sight Medical Products.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 2
- Study locations
NCT03344848 is a NA study of Blindness, Acquired that is active but no longer recruiting, run by Second Sight Medical Products. The registered enrollment target is 6 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03344848, a NA study of Blindness, Acquired, is active but no longer recruiting, sponsored by Second Sight Medical Products.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perception in blind individuals.
Conditions Studied
Interventions
- DEVICE Orion Visual Cortical Prosthesis System
Study Locations (2)
California
- University of California, Los Angeles - Los Angeles
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-11-20 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03344848
The ClinicalTrials.gov registry entry for NCT03344848 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Second Sight Medical Products, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blindness, Acquired appearing as the primary indexed condition, and to 1 intervention - of which Orion Visual Cortical Prosthesis System is the first listed.
NCT03344848 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.
Frequently Asked Questions
What is clinical trial NCT03344848 about?
NCT03344848 is a clinical study titled "Early Feasibility Study of the Orion Visual Cortical Prosthesis System". This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perception in blind individuals.
What is the current status of trial NCT03344848?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2017-11-20. Estimated completion is 2025-03-31.
What conditions does trial NCT03344848 study?
This clinical trial studies the following conditions: Blindness, Acquired.
What interventions are being tested in trial NCT03344848?
The interventions under investigation include: Orion Visual Cortical Prosthesis System (DEVICE).
Who is sponsoring clinical trial NCT03344848?
This trial is sponsored by Second Sight Medical Products, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03344848 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blindness, Acquired
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.